PHT, CMIC Establish a Support Network for Electronic Clinical Trial Data Capture Systems

PHT, CMIC Establish a Support Network for Electronic Clinical Trial Data Capture Systems

BOSTON --(Business Wire)-- Jul 15, 2009 PHT Corporation and CMIC Co., Ltd. announced an operational alliance to provide a consolidated service network for Japanese pharmaceutical companies to use PHT's ePRO solutions in conducting clinical trials. PHT is the leading provider of ePRO solutions used in more than 400 clinical trials worldwide. CMIC Group is Japan's first CRO.

CMIC Group has been developing a business model which fully supports the medical business of pharmaceutical companies, encompassing development, production and marketing, and which makes a contribution to value-added improvements. Among its core operations as a CRO and health care-related business concern, CMIC supports trouble-free implementation of clinical trials for both sponsors and investigational sites by conducting operations including clinical trial monitoring, data management, subject recruitment, and trial coordination.

About CMIC Co., Ltd.

As Japan's first CRO, CMIC supports pharmaceutical and clinical industries from drug development through manufacture to marketing, by providing pharmaceutical consulting, monitoring, and data management services. CMIC also supports development activities for medical devices by carrying out pharmaceutical consulting, clinical trials and approval applications. CMIC maintains a global presence with extensive business practices in Japan, Asia (China, Korea, Singapore, Taiwan), and America among other territories. For further details please visit the website, http://www.cmic.co.jp/.

About PHT Corporation

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 400 clinical trials by 100 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePadTM Tablet deliver the voice of the patient, in 85 languages, from homes and sites in 64 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, trial sponsors are able to run smaller and more conclusive clinical research programs resulting in significant R&D cost savings. Real-time study management through PHT StudyWorksTM features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPROTM email alerts, and the industry's premier study archive. Patient experiences captured firsthand by PHT's ePRO Product Suite have been used successfully in at least 12 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com.

PHT, LogPad, eSense, StudyWorks, SafetyPRO and SitePad are among the registered trademarks and trademarks of PHT Corporation.

Suggested Articles

Inovio CEO J. Joseph Kim is undeterred by short sellers and other detractors who doubt his company can shuttle a COVID-19 DNA vaccine to market.

Adding entinostat to hormone therapy did not help patients with HR-positive, HER2-negative breast cancer live longer.

The data add to the evidence in support of the IL-6 drug ahead of a FDA decision to approve it in a rare disease served by Alexion’s Soliris.